Skip to main content

DCVC — Portfolio, Page 10

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

293
Companies
$8.5B
Total invested
$35.6M
Avg. check
57
Industries
Software 7Biotechnology 5Artificial Intelligence (AI) 5Big Data 5Information Technology 5Analytics 4+51 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 217–240 of 293
Novome Biotechnologies
September 2022

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

Biopharma · South San Francisco$43.5M Series B
Verdant Robotics, Inc.
August 2022

Verdant builds AI-powered Smart Sprayers that weed, thin, fertilize & deliver nutrients at millimeter level.

Agriculture · Hayward$46.5M Series A
Rill Data
August 2022

Rill Data is a simple alternative to complex BI stacks—the fastest, easiest path from data to metrics dashboards.

Analytics · San Francisco$12.0M Seed
Petra
June 2022

Petra is a Robotics company that focuses solely on underground utilities.

Civil Engineering · San FranciscoSeries Unknown
Fletch
April 2022

Fletch provides ready-to-use analytics organized in solutions sets that are easy to understand and actionable on day one.

Analytics · San Francisco$12.6M Series A
zkLend
March 2022

zkLend is an L2 money-market protocol built on StarkNet, combining zk-rollup scalability, superior transaction speed, and cost-savings.

Cryptocurrency · Hong Kong$5.0M Seed
Creyon Bio
March 2022

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

Biotechnology · San Diego$40.0M Series A
Health Gorilla
March 2022

Health Gorilla is the Federally Qualified Health Information Network

Electronic Health Record (EHR) · Mountain View$50.0M Series C
Lucira Health
February 2022

Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.

Biotechnology · Emeryville$80.0M Post Ipo Debt
nTopology
November 2021

nTopology is a company that develops software used in the design and manufacturing of 3D-printed parts and products.

3D Printing · New York$65.0M Series D
Kettle
November 2021

Kettle is an insurtech company that develops a machine-learning powered reinsurer balancing risk.

Financial Services · Hamilton$25.0M Series A
Nyriad
November 2021

Nyriad is developing the industry's first storage solutions based on a new architecture that redefines how data is stored.

Computer · Austin$28.0M Series C
Zoom
November 2021

Zoom is a software company that offers a communications platform that connects people through video, voice, chat, and content sharing.

Collaboration · San Jose$130.0M Post Ipo Equity
Kentik
October 2021

Kentik is the network intelligence platform for modern infrastructure teams

Cloud Data Services · San Francisco$40.0M Series C
Pluribus Networks
October 2021

Pluribus Networks is a leader in open networking and next generation software defined networking (SDN)

Big Data · Santa Clara$20.0M Series Unknown
MindRhythm
August 2021

MindRhythm is an evolved neurodiagnostics company discovering and developing unique biometrics to solve unmet needs in medicine.

Manufacturing · Cupertino$5.0M Seed
Stemson Therapeutics
July 2021

Stemson Therapeutics is a pre-clinical stage cell therapy company.

Biotechnology · San Diego$15.0M Series A
Cape Analytics
July 2021

Cape Analytics provides AI and analytics services for properties.

Analytics · Palo Alto$44.0M Series C
Nylas
June 2021

Nylas is the cpaas company that empowers businesses worldwide to unlock the power of their communications data.

Developer APIs · San Francisco$120.0M Series C
Paperspace
May 2021

Paperspace powers next-generation applications built on GPUs.

AI Infrastructure · New York$12.0M Series Unknown
InnaMed
May 2021

InnaMed is a developer of a diagnostic device intended to provide early detection of illness.

Health Care · PhiladelphiaSeries Unknown
BioPhero
March 2021

BioPhero is a pioneer in providing low-cost bio-based pheromones for pest management.

Chemical · Lyngby$16.8M Series A
Auransa
August 2020

A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform

Artificial Intelligence (AI) · Palo Alto$15.7M Series A
Pachyderm
August 2020

Pachyderm is an enterprise-grade data science platform that makes explainable, repeatable, and scalable AI/ML a reality.

Analytics · San Francisco$16.0M Series B

Where DCVC invests

Software7
Biotechnology5
Artificial Intelligence (AI)5
Big Data5
Information Technology5
Analytics4

About DCVC's portfolio

How many companies has DCVC invested in?▸

DCVC has invested in 293 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does DCVC invest in?▸

DCVC's top investment sectors include Software, Biotechnology, Artificial Intelligence (AI), Big Data, Information Technology. The firm invests across 57 different industry categories.

What is DCVC's largest investment?▸

Among tracked funding rounds, Zoom received $130.0M in a Post Ipo Equity round. DCVC's total known invested capital is $8.5B.

What is the average investment size for DCVC?▸

DCVC's average investment size is $35.6M across its portfolio of 293 companies.

What are DCVC's most recent investments?▸

Recent DCVC portfolio additions include Novome Biotechnologies, Verdant Robotics, Inc., Rill Data, Petra, Fletch. These companies were founded in 2020 or later.

Reach the founders behind these 293 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →